期刊文献+

低氧反应元件对缺血心肌转导hVEGF_(165)基因表达的调控 被引量:1

Hypoxic response elements regulate the expression of human vascular endothelial growth factor gene transferred to ischemia and reperfusion myocardium
下载PDF
导出
摘要 目的探讨低氧反应元件(hypoxic response element,HRE)对缺血、复灌心肌转导人血管内皮生长因子165(human vascular endous growth factor 165,hVEGF165)基因表达的调控作用。方法在猪冠状动脉回旋支起始处以钛夹阻断回旋支血流,建立可复灌的心肌缺血模型。携带9拷贝HRE(9HRE)-hVEGF165的腺相关病毒转染模型心肌,转染后4天,复灌组二次开胸打开钛夹恢复缺血区血供。取各组心肌组织,RT-PCR法测定hVEGF165mRNA的表达情况;免疫组化及免疫印迹法测定hVEGF165蛋白的表达情况;Ⅷ因子免疫组化染色检测局部毛细血管情况。结果缺血心肌转导hVEGF165基因后,hVEGF165蛋白表达量明显增高,而复灌组表达明显减少(P<0.01)。结论9HRE作为调控缺血心肌组织内转导的hVEGF165基因的氧敏感开关灵敏、高效,使hVEGF165基因在缺血时高度表达,而复灌后表达水平下降。 Objective To investigate how the nine copies hypoxic response elements (9HRE) regulate the expression of human vascular endothelial growth factor 165 (hVEGF165) gene transferred by adeno- associated vector into ischemia and reperfusion myocardium in vivo. Methods 24 male swine ischemic myocardium models were made through left lateral fourth intercostal thoracotomy by placing a titanium clamp on the proximal left circumflex artery. Recombinant adeno - associated viral (rAAV - 9HRE - hVEGF165 ) vectors or PBS was injected into the ischemic myocardium. The titanium clamp in reperfusion group was released under thoracotomy 4 days after gene transfer. 8 days after gene transfer, Ⅷ factor staining was performed, hVEGF165 protein was tested by Western blot and i mmunochemistry, hVEGF165 mRNA was detected after reverse transcription polymerase chain reaction (RT- PCR). Results The expression of hVEGF165 increased in ischemic myocardium significantly and decreased rapidly after reperfusion. Conclusion The expression level of transferred hVEGF165 gene rises in ischemia and declines under reperfusion. 9HRE could regulate the gene expression in response to the oxygen environment.
出处 《徐州医学院学报》 CAS 2006年第5期381-385,共5页 Acta Academiae Medicinae Xuzhou
基金 江苏省教育厅重点资助项目(03JKA310140)
关键词 低氧反应元件 基因调控 人血管内皮生长因子165 腺相关病毒 心肌 hypoxic response elements gene regulation human vascular endothelial growth factor 165 recombinant adeno- associated virus myocardium
  • 相关文献

参考文献6

  • 1Isner JM.Myocardial gene therapy[J].Nature,2002,415(6868):234-239.
  • 2Lee RJ,Springer ML,Blanco-Bose WE,et al.VEGF gene delivery to myocardium deleterious effects of unregulated expression[J].Circulation,2000,102(8):898-901.
  • 3张中明,姜波,董红燕,张宜乾.低氧反应元件对低氧复氧状态下心肌细胞转染人血管内皮生长因子_(165)基因表达的调控作用[J].中华实验外科杂志,2005,22(12):1510-1512. 被引量:8
  • 4Su H,Arakawa-Hoyt J,Kan YW.Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression inmouse ischemic heart model[J].PNAS,2002,99(14):9480-9485.
  • 5Kimura H,Weisz A,Kurashima Y,et al.Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide:control of hypoxia-inducible factor-1 activity by nitric oxide[J].Blood,2000,95(1):189-197.
  • 6Huang LE,Bunn HF.Hypoxia-inducible factor and its biomedical relevance[J].J Biol Chem,2003,278(22):19575-19578.

二级参考文献8

  • 1Isner J. Myocardial gene therapy. Nature, 2002, 415 : 234-239.
  • 2Garrett DJ, Cohen JC. & Larson JE. Long term physiologic modification using rAAV in utero gene-therapy. Genet Vaccines Ther, 2004,2:4.
  • 3Lee R J, Springer ML, Blanco-Bose WE, et al. VEGF gene delivery to myocardium deleterious effects of unregulated expression. Circulation,2000, 102:898-901.
  • 4Henry TD, Annex BH, Mckendall GR, et al. The VIVA trail: VEGF in ischemia for vascular angiogenesis. Circulation, 2003, 107 : 1359.
  • 5Voutetakis A, Kok MR, Zheng C, et al. Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. PNAS,2004, 101:3053-3058.
  • 6Huser D, Weger S, Hei|bronn R. Packaging of human chromosome 19-specific adeno-associated virus (AAV) integration sites in AAV virus during AAV wild-type and recombinant AAV vector production. J Virology, 2003, 4:4881-4887.
  • 7Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional acti-vation. Mol Cell Bio, 1992, 12:5447-5454.
  • 8Huang LE, Bunn HF. Hypoxia-inducible factor and its biomedical relevance. Biol Chem, 2003,278 : 19575-19578.

共引文献7

同被引文献32

  • 1张中明,姜波,董红燕,张宜乾.低氧反应元件对低氧复氧状态下心肌细胞转染人血管内皮生长因子_(165)基因表达的调控作用[J].中华实验外科杂志,2005,22(12):1510-1512. 被引量:8
  • 2张宜乾,张中明,闫英群,董红燕.低氧反应元件调控下h-VEGF_(165)基因表达及其蛋白产物的延迟消失[J].生理学报,2006,58(3):281-286. 被引量:6
  • 3Evans M J, Kaufman MH.Establishment in culture of pluripotential cells from mouse embryos.Nature. 1981 ;292 (5819):154-156.
  • 4Amit M, Carpenter MK, Inokuma MS,et al.CIonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture.Dev Biol 2000;227(2):271-278.
  • 5Kubo A, Shinozaki K, Shannon JM,et al.Development of definitive endoderm from embryonic stem cells in culture. Development. 2004; 131 (7): 1651-1662.
  • 6Bai H, Wang ZZ.Directing human embryonic stem cells to generate vascular progenitor cells.Gene Ther. 2008; 15(2): 89-95.
  • 7Levenberg S.Engineering blood vessels from stem cells: recent advances and applications.Curt Opin Biotechnol. 2005; 16(5):516-523.
  • 8Kusuma S, Gerecht S.Engineering blood vessels using stern cells: innovative approaches to treat vascular disorders. Expert Rev Cardiovasc Ther. 2010;8(10):1433-1445.
  • 9Sun G, Gerecht S.Vascular regeneration: engineering the stem cell microenvironment. Regen Med. 2009;4(3):435-447.
  • 10Wang ZZ., Au P, Chen T, et al.Endothelial cells derived from human.embryonic stem cells form durable blood vessels in vivo.Nat Biotechnol. 2007;25(3):317-318.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部